Tolerability and Safety of 30, 45, and 60 mg of Sublingual Lobeline. - 1

NCT00519259 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

12

Enrollment

NIH

Sponsor class

Conditions

Methamphetamine Dependence

Interventions

DRUG: Lobeline

Sponsor

National Institute on Drug Abuse (NIDA)